High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.

Geahča maid

• High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
  Dahkki: Mitchell, S, et al.
  Almmustuhtton: (1997)
• Down regulation of interferon gamma and up regulation of interleukin-10 by ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC).
  Dahkki: Mitchell, SA, et al.
  Almmustuhtton: (1997)
• High-dose ursodeoxycholic acid in primary sclerosing cholangitis a randomised double-blind placebo-controlled trial
  Dahkki: Bansi, D, et al.
  Almmustuhtton: (1996)
• A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
  Dahkki: Mitchell, SA, et al.
  Almmustuhtton: (2001)
• URSODEOXYCHOLIC ACID IN PRIMARY SCLEROSING CHOLANGITIS - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
  Dahkki: Lo, S, et al.
  Almmustuhtton: (1992)